发布求助
文献互助 智能选刊 最新文献

Immuno-oncology technology最新文献

筛选
英文 中文
32P Immune T cell subsets dynamics in the early TNBC treatment setting 32P免疫T细胞亚群动态在早期TNBC治疗设置
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100914
R. Martín Lozano , N. Jiménez-Alduán , I. Echavarria Diaz-Guardamino , M. Del Monte , Y. Jerez Gilarranz , B. Herrero Lopez , P. Jara , F. Moreno Anton , J.Á. García Saenz , C. Bueno Muiño , A.I. Ballesteros Garcia , A. López de Sá , M. Cebollero , P. Rahimi Mousavi , E. Alvarez , S. Misiego , T. Massarrah , C. Polo , M. Martin Jimenez , S. Lopez-Tarruella Cobo
{"title":"32P Immune T cell subsets dynamics in the early TNBC treatment setting","authors":"R. Martín Lozano , N. Jiménez-Alduán , I. Echavarria Diaz-Guardamino , M. Del Monte , Y. Jerez Gilarranz , B. Herrero Lopez , P. Jara , F. Moreno Anton , J.Á. García Saenz , C. Bueno Muiño , A.I. Ballesteros Garcia , A. López de Sá , M. Cebollero , P. Rahimi Mousavi , E. Alvarez , S. Misiego , T. Massarrah , C. Polo , M. Martin Jimenez , S. Lopez-Tarruella Cobo","doi":"10.1016/j.iotech.2024.100914","DOIUrl":"10.1016/j.iotech.2024.100914","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100914"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5MO Novel radiologic phenotypes of chaotic tumor angiogenesis associated with poor ICI outcomes in NSCLC 与非小细胞肺癌不良ICI预后相关的混乱肿瘤血管生成的新放射学表型
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100889
V. Velcheti , R. Chitalia , C. Leibowitz , K. Zhang , A. Madabhushi , N. Braman
{"title":"5MO Novel radiologic phenotypes of chaotic tumor angiogenesis associated with poor ICI outcomes in NSCLC","authors":"V. Velcheti , R. Chitalia , C. Leibowitz , K. Zhang , A. Madabhushi , N. Braman","doi":"10.1016/j.iotech.2024.100889","DOIUrl":"10.1016/j.iotech.2024.100889","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100889"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143132190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
49P Highly potent novel armoured IL13Ra2 CAR T cell targeting glioblastoma 靶向胶质母细胞瘤的高效新型装甲IL13Ra2 CAR - T细胞
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100860
M. Mangolini , S. Srivastava , E. Souster , Y. Yang , R. Karatill , L. Schultz , B. Ma , D. Pombal , A. Ramon , M. Greenig , P. Sormanni , S. Cordoba , S. Onuoha
{"title":"49P Highly potent novel armoured IL13Ra2 CAR T cell targeting glioblastoma","authors":"M. Mangolini , S. Srivastava , E. Souster , Y. Yang , R. Karatill , L. Schultz , B. Ma , D. Pombal , A. Ramon , M. Greenig , P. Sormanni , S. Cordoba , S. Onuoha","doi":"10.1016/j.iotech.2024.100860","DOIUrl":"10.1016/j.iotech.2024.100860","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100860"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143129092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
48P The A2AR antagonist inupadenant promotes humoral responses in preclinical models A2AR拮抗剂inupadenant在临床前模型中促进体液反应
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.101008
P. Tieppo , M. Mercier , S. Jung , D. Carbonez , L. Chaible , R. Marillier , F. Strozzi , M-C. Dieu-Nosjean , H. Shehade , Y. McGrath , M. Rossetti
{"title":"48P The A2AR antagonist inupadenant promotes humoral responses in preclinical models","authors":"P. Tieppo , M. Mercier , S. Jung , D. Carbonez , L. Chaible , R. Marillier , F. Strozzi , M-C. Dieu-Nosjean , H. Shehade , Y. McGrath , M. Rossetti","doi":"10.1016/j.iotech.2024.101008","DOIUrl":"10.1016/j.iotech.2024.101008","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 101008"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
26P Liquid biopsy-based percision immunotherapy: CCAT1 and HEIH lncRNAs identify young breast cancer patients likely to respond to PD-L1 blockade 基于液体活检的精准免疫治疗：CCAT1和HEIH lncrna可识别可能对PD-L1阻断有反应的年轻乳腺癌患者
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100908
R.A. Youness , A. Mohamed , M.B. Yasser , H.M. Nafea , T. Manie , F. Rashid , M. Ragheb
{"title":"26P Liquid biopsy-based percision immunotherapy: CCAT1 and HEIH lncRNAs identify young breast cancer patients likely to respond to PD-L1 blockade","authors":"R.A. Youness , A. Mohamed , M.B. Yasser , H.M. Nafea , T. Manie , F. Rashid , M. Ragheb","doi":"10.1016/j.iotech.2024.100908","DOIUrl":"10.1016/j.iotech.2024.100908","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100908"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
101P Comparison on the effectiveness of multiple single and double immunotherapy treatments on advanced angiosarcoma patients: Meta analysis & systematic review 101P单、双免疫治疗晚期血管肉瘤的疗效比较：Meta分析与系统评价
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100844
E. Marson
{"title":"101P Comparison on the effectiveness of multiple single and double immunotherapy treatments on advanced angiosarcoma patients: Meta analysis & systematic review","authors":"E. Marson","doi":"10.1016/j.iotech.2024.100844","DOIUrl":"10.1016/j.iotech.2024.100844","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100844"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
65O CheckMate 73L: Phase III study comparing nivolumab (N) + concurrent chemoradiotherapy (CCRT) followed by N ± ipilimumab (I) v CCRT followed by durvalumab (D) for previously untreated, locally advanced stage (stg) III NSCLC 65O CheckMate 73L: III期研究比较尼武单抗(N) +同步放化疗(CCRT) + N±伊匹单抗(I) vs CCRT + durvalumab (D)治疗先前未治疗的局部晚期（stg） III期NSCLC
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100808
S. Peters , D.S.W. Tan , D.E. Gerber , J. Urbanic , S.S. Ramalingam , J. Yu , L. Xing , A. Rittmeyer , T-E. Ciuleanu , J. Menezes , H.R. Kim , C.I. Rojas , K. Syrigos , H. Hayashi , A. Haridass , S. Bordenave , R. Nathani , G. Pudussery , L. Yang , D. De Ruysscher
{"title":"65O CheckMate 73L: Phase III study comparing nivolumab (N) + concurrent chemoradiotherapy (CCRT) followed by N ± ipilimumab (I) v CCRT followed by durvalumab (D) for previously untreated, locally advanced stage (stg) III NSCLC","authors":"S. Peters , D.S.W. Tan , D.E. Gerber , J. Urbanic , S.S. Ramalingam , J. Yu , L. Xing , A. Rittmeyer , T-E. Ciuleanu , J. Menezes , H.R. Kim , C.I. Rojas , K. Syrigos , H. Hayashi , A. Haridass , S. Bordenave , R. Nathani , G. Pudussery , L. Yang , D. De Ruysscher","doi":"10.1016/j.iotech.2024.100808","DOIUrl":"10.1016/j.iotech.2024.100808","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100808"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
92P An investigation on the differences between the pre-treatment nutritional and immunological status of nasopharyngeal carcinoma patients and the healthy population 鼻咽癌患者治疗前营养及免疫状况与健康人群差异的研究
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100835
Q. He , M. Yang , D. Wang , Y. Huang
{"title":"92P An investigation on the differences between the pre-treatment nutritional and immunological status of nasopharyngeal carcinoma patients and the healthy population","authors":"Q. He , M. Yang , D. Wang , Y. Huang","doi":"10.1016/j.iotech.2024.100835","DOIUrl":"10.1016/j.iotech.2024.100835","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100835"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
95P Quality of life (QoL) and care pathway in patients with durable response to immune checkpoint inhibitors (ICI-DR) for advanced or metastatic non-small cell lung cancer (NSCLC) or melanoma: QUALICI study 晚期或转移性非小细胞肺癌（NSCLC）或黑色素瘤患者对免疫检查点抑制剂（ICI-DR）持久反应的生活质量（QoL）和护理途径：QUALICI研究
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100838
N. Girard , J. Bonastre , G. Spurrier-Bernard , H. Lemasson , M. Chartier , V. Moreau-Mallet , S. Micheliza , N. Texier , S. Hervy , M. Coin-Bavarot , C. Robert
{"title":"95P Quality of life (QoL) and care pathway in patients with durable response to immune checkpoint inhibitors (ICI-DR) for advanced or metastatic non-small cell lung cancer (NSCLC) or melanoma: QUALICI study","authors":"N. Girard , J. Bonastre , G. Spurrier-Bernard , H. Lemasson , M. Chartier , V. Moreau-Mallet , S. Micheliza , N. Texier , S. Hervy , M. Coin-Bavarot , C. Robert","doi":"10.1016/j.iotech.2024.100838","DOIUrl":"10.1016/j.iotech.2024.100838","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100838"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41P Total tumor burden and radiomics to evaluate response in dose escalation studies: Roginolisib (IOA-244), a highly selective PI3Kδ inhibitor in metastatic uveal melanoma patients 总肿瘤负荷和放射组学评估剂量递增研究的反应：Roginolisib (IOA-244)，转移性葡萄膜黑色素瘤患者的高选择性PI3Kδ抑制剂
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.101001
A.M. Di Giacomo , A. Corsi , N. Sindhwani , A. Rasooli , M.H. Nawaz , F. Belmans , C.C. Meca , M. Maio , T.R.J. Evans , A. Santoro , M. Lahn , W. Vos
{"title":"41P Total tumor burden and radiomics to evaluate response in dose escalation studies: Roginolisib (IOA-244), a highly selective PI3Kδ inhibitor in metastatic uveal melanoma patients","authors":"A.M. Di Giacomo , A. Corsi , N. Sindhwani , A. Rasooli , M.H. Nawaz , F. Belmans , C.C. Meca , M. Maio , T.R.J. Evans , A. Santoro , M. Lahn , W. Vos","doi":"10.1016/j.iotech.2024.101001","DOIUrl":"10.1016/j.iotech.2024.101001","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 101001"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信